Anne Monroe, M.D., M.S.P.H.

Latest by Anne Monroe, M.D., M.S.P.H.

Understanding and Managing Peripheral Neuropathy

Table of Contents

Introduction A Snapshot of the Nervous System Clinical Features of Peripheral Neuropathy Development of DSPN Diagnosing DSPN Risk Factors for DSPN Neuropathy Management DSPN Therapies Conclusion Selected Sources

...

By Anne Monroe, M.D., M.S.P.H. for San Francisco AIDS Foundation

HIV/AIDS and Diabetes: Minimizing Risk, Optimizing Care

Recent literature about diabetes and disorders of glucose metabolism in people with HIV/AIDS contains conflicting messages. Some studies indicate an increased risk of diabetes mellitus (generally referred to simply as "diabetes") in people taking H...

By Anne Monroe, M.D., M.S.P.H. for San Francisco AIDS Foundation

Drug Watch: TH9507 -- An Experimental Treatment for Lipodystrophy

Introduction Lipodystrophy Treating Lipodystrophy with Growth Hormone Products TH9507: A New Treatment Option? Conclusion Selected Sources

Introduction

As the use of highly active antiretroviral therapy (HAART) became widespread, HIV po...

By Anne Monroe, M.D., M.S.P.H. for San Francisco AIDS Foundation

The Latest on OI Prophylaxis: When to Start, When to Stop

Long before HAART, the use of medications to prevent opportunistic infections (prophylaxis) was an important component of HIV care. And while there has been a decrease in the incidence of opportunistic infections since the introduction of HAART, payi...

By Anne Monroe, M.D., M.S.P.H. for AIDS Community Research Initiative of America